DNAJC19
Basic information
Region (hg38): 3:180983697-180989774
Links
Phenotypes
GenCC
Source:
- 3-methylglutaconic aciduria type 5 (Strong), mode of inheritance: AR
- 3-methylglutaconic aciduria type 5 (Supportive), mode of inheritance: AR
- 3-methylglutaconic aciduria type 5 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
3-methylglutaconic aciduria, type V | AR | Cardiovascular | Individuals frequently demonstrate findings including cardiac manifestations such as dilated cardiomyopathy and dysrhythmias, and surveillance may allow early detection and management | Biochemical; Cardiovascular; Gastrointestinal; Genitourinary; Hematologic; Neurologic; Ophthalmologic | 16055927; 22981120 |
ClinVar
This is a list of variants' phenotypes submitted to
- 3-methylglutaconic aciduria type 5 (6 variants)
- 3-Methylglutaconic aciduria type 3 (1 variants)
- DNAJC19-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJC19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 16 | ||||
missense | 35 | 35 | ||||
nonsense | 3 | |||||
start loss | 2 | |||||
frameshift | 7 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 4 | 9 | 1 | 14 | ||
non coding | 27 | 39 | ||||
Total | 6 | 8 | 46 | 44 | 8 |
Highest pathogenic variant AF is 0.0000460
Variants in DNAJC19
This is a list of pathogenic ClinVar variants found in the DNAJC19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-180984096-T-TAC | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jun 14, 2016) | ||
3-180984152-C-G | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jun 14, 2016) | ||
3-180984442-ATAAT-A | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jun 14, 2016) | ||
3-180984452-C-T | Benign (Jun 23, 2018) | |||
3-180984642-AT-A | 3-methylglutaconic aciduria type 5 | Uncertain significance (Aug 15, 2022) | ||
3-180984643-T-C | 3-methylglutaconic aciduria type 5 | Likely benign (Nov 07, 2021) | ||
3-180984647-T-C | 3-methylglutaconic aciduria type 5 | Uncertain significance (Oct 03, 2022) | ||
3-180984658-T-C | 3-methylglutaconic aciduria type 5 | Likely benign (Feb 11, 2023) | ||
3-180984659-T-G | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jul 11, 2022) | ||
3-180984660-C-G | 3-methylglutaconic aciduria type 5 • not specified • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jun 25, 2024) | ||
3-180984660-C-T | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jan 23, 2022) | ||
3-180984665-A-G | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jul 17, 2022) | ||
3-180984666-A-C | 3-methylglutaconic aciduria type 5 | Uncertain significance (Jun 11, 2021) | ||
3-180984675-C-T | 3-methylglutaconic aciduria type 5 | Uncertain significance (Apr 24, 2022) | ||
3-180984690-CT-C | 3-methylglutaconic aciduria type 5 | Pathogenic (Oct 01, 2012) | ||
3-180984691-T-C | 3-methylglutaconic aciduria type 5 | Likely benign (Jan 12, 2024) | ||
3-180984695-A-AT | 3-methylglutaconic aciduria type 5 | Uncertain significance (Dec 11, 2023) | ||
3-180984696-T-C | 3-methylglutaconic aciduria type 5 • Inborn genetic diseases | Uncertain significance (May 14, 2024) | ||
3-180984697-A-G | 3-methylglutaconic aciduria type 5 | Likely benign (Jan 31, 2023) | ||
3-180984698-T-TA | Likely pathogenic (Jan 01, 2021) | |||
3-180984703-A-C | 3-methylglutaconic aciduria type 5 | Likely benign (Aug 07, 2021) | ||
3-180984706-T-G | not specified • 3-methylglutaconic aciduria type 5 | Benign/Likely benign (Nov 01, 2024) | ||
3-180984710-C-A | Uncertain significance (Feb 12, 2021) | |||
3-180984712-T-G | 3-methylglutaconic aciduria type 5 | Likely pathogenic (Mar 17, 2024) | ||
3-180984714-T-A | DNAJC19-related disorder | Likely benign (Jun 10, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJC19 | protein_coding | protein_coding | ENST00000382564 | 6 | 6066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000613 | 0.741 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.876 | 44 | 63.7 | 0.691 | 0.00000336 | 747 |
Missense in Polyphen | 8 | 14.931 | 0.5358 | 197 | ||
Synonymous | 0.152 | 18 | 18.8 | 0.955 | 9.07e-7 | 216 |
Loss of Function | 0.934 | 6 | 9.03 | 0.664 | 5.47e-7 | 97 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000570 | 0.000570 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000976 | 0.000971 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. May act as a co-chaperone that stimulate the ATP-dependent activity (By similarity). {ECO:0000250}.;
- Pathway
- Metabolism of proteins;Mitochondrial protein import
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.672
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- 0.247
- hipred
- Y
- hipred_score
- 0.788
- ghis
- 0.648
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajc19
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- protein folding;protein targeting to mitochondrion;visual perception;protein import into mitochondrial matrix;positive regulation of ATPase activity;genitalia development
- Cellular component
- PAM complex, Tim23 associated import motor;mitochondrion;mitochondrial inner membrane;integral component of membrane;protein-containing complex
- Molecular function
- ATPase activator activity;protein binding;protein transporter activity